Cargando…

Polymorphism in miR-146a associated with clinical characteristics and outcomes in gastric cancer patients treated with adjuvant oxaliplatin and fluoropyrimidines

PURPOSE: Polymorphism in miR-146a (rs2910164) has been reported to be associated with gastric cancer risk in the Chinese population. We aimed at evaluating the relationship between rs2910164 and the clinical characteristics and outcomes in stage IB–III gastric cancer patients treated with adjuvant c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Yu-Qian, Liao, Yu-Lu, Li, Jun, Peng, Li-Xiang, Wan, Yi-Ye, Zhong, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577269/ https://www.ncbi.nlm.nih.gov/pubmed/26396533 http://dx.doi.org/10.2147/OTT.S89635

Ejemplares similares

Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
por: SU, YUQI, et al.
Publicado: (2015)

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
por: Lee, Dae-Won, et al.
Publicado: (2019)

Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin
por: Jiang, Jingting, et al.
Publicado: (2011)

Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms
por: Deng, Xunwei, et al.
Publicado: (2020)

The Associations of Single Nucleotide Polymorphisms in miR-146a, miR-196a and miR-499 with Breast Cancer Susceptibility
por: Wang, Ping-Yu, et al.
Publicado: (2013)

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
por: Ruzzo, Annamaria, et al.
Publicado: (2014)

Association between Ankylosing Spondylitis and the miR-146a and miR-499 Polymorphisms
por: Xu, Hui Ying, et al.
Publicado: (2015)

MiR-146a rs2910164 G/C polymorphism and gastric cancer susceptibility: a meta-analysis
por: Xu, Zhong, et al.
Publicado: (2014)

miR-135a promotes gastric cancer progression and resistance to oxaliplatin
por: Yan, Lin-Hai, et al.
Publicado: (2016)

Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer.
por: Lee, J. H., et al.
Publicado: (2001)

miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma
por: Qiu, Zhenwei, et al.
Publicado: (2017)

MiR-146a and miR-155 polymorphisms in Egyptian patients with Behcet’s disease
por: Shaker, Olfat G., et al.
Publicado: (2021)

Genetic Polymorphisms of miR-146a and miR-27a, H. pylori Infection, and Risk of Gastric Lesions in a Chinese Population
por: Song, Ming-yang, et al.
Publicado: (2013)

Correction: Genetic Polymorphisms of miR-146a and miR-27a, H. pylori Infection, and Risk of Gastric Lesions in a Chinese Population
por: Song, Ming-yang, et al.
Publicado: (2014)

Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b
por: Cho, Sunglim, et al.
Publicado: (2018)

Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer
por: Mobayed, Mohammad, et al.
Publicado: (2009)

Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid Cancer
por: Zhang, Xin, et al.
Publicado: (2015)

Common functional polymorphism within miR-146a and miR-196a-2 as susceptibility loci for hepatocellular carcinoma: An updated meta-analysis
por: Chen, Ming, et al.
Publicado: (2015)

Associations between miR-146a rs2910164 polymorphisms and risk of ischemic cardio-cerebrovascular diseases
por: Zhao, Dongdong, et al.
Publicado: (2019)

Lack of association of miR-146a and Ets-1 gene polymorphisms with Fuchs uveitis syndrome in Chinese Han patients
por: Zhou, Qingyun, et al.
Publicado: (2012)

The Functional Polymorphisms of miR-146a Are Associated with Susceptibility to Severe Sepsis in the Chinese Population
por: Shao, Yiming, et al.
Publicado: (2014)

Effects of Two Common Polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on Gastric Cancer Susceptibility
por: Ni, Qing, et al.
Publicado: (2015)

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
por: Iveson, Timothy J, et al.
Publicado: (2018)

Association of the miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms with susceptibility to pulmonary tuberculosis in the Chinese Uygur, Kazak and Southern Han populations
por: Zhang, Xing, et al.
Publicado: (2015)

Affection of Single-Nucleotide Polymorphisms in miR-27a, miR-124a, and miR-146a on Susceptibility to Type 2 Diabetes Mellitus in Chinese Han People
por: Wang, Tong-Tong, et al.
Publicado: (2015)

Genetic variant of miR-146a rs2910164 C>G and gastric cancer susceptibility
por: Xia, Zu-Guang, et al.
Publicado: (2016)

Impact of Intratumoral Expression Levels of Fluoropyrimidine-Metabolizing Enzymes on Treatment Outcomes of Adjuvant S-1 Therapy in Gastric Cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2015)

Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy
por: Huang, Ching-Wen, et al.
Publicado: (2021)

A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study
por: Zhang, Weigang, et al.
Publicado: (2014)

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience
por: Adams, R A, et al.
Publicado: (2009)

The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer
por: Kim, Seong-Geun, et al.
Publicado: (2016)

MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females
por: Yin, Zhihua, et al.
Publicado: (2016)

Association of miR-146a, miR-149, miR-196a2, miR-499 gene polymorphisms with ischemic stroke in a Chinese people
por: Luo, Hong-Cheng, et al.
Publicado: (2017)

miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1
por: Li, Kui, et al.
Publicado: (2020)

Genetic Variants miR-126, miR-146a, miR-196a2, and miR-499 in Polycystic Ovary Syndrome
por: Li, R., et al.
Publicado: (2022)

MiR-146a in Immunity and Disease
por: Rusca, Nicole, et al.
Publicado: (2011)

miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet’s disease
por: Hou, Shengping, et al.
Publicado: (2016)

Meta-Analysis of miR-146a Polymorphisms Association with Coronary Artery Diseases and Ischemic Stroke
por: Bao, Mei-Hua, et al.
Publicado: (2015)

Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis
por: Wu, Lili, et al.
Publicado: (2021)

MiR-146 and miR-125 in the regulation of innate immunity and inflammation
por: Lee, Hye-Mi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sjqdjil0m3o0fgv59ao40tqikf